ReviewCureus2026
Renal Dysfunction and Cardiorenal Syndrome in Acute Heart Failure: A Systematic Review of Residual Congestion and Decongestion Response.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal dysfunction is common during hospitalization for acute heart failure and is traditionally considered a defining feature of cardiorenal syndrome type 1. However, the prognostic significance of worsening renal function may depend on the clinical context, particularly whether congestion persists or effective decongestion is achieved. This systematic review evaluated contemporary evidence regarding the relationships among renal dysfunction, residual congestion, decongestion response, and clinical outcomes in adults hospitalized with acute heart failure or cardiorenal syndrome type 1. PubMed/MEDLINE, Scopus, and Web of Science were systematically searched for studies published between January 1, 2021, and December 31, 2025. Eligible studies included randomized controlled trials, prespecified analyses of clinical trials, and post hoc analyses of trial-derived data that reported both renal and congestion-related outcomes. Five studies met the inclusion criteria. Residual congestion was consistently associated with worse clinical outcomes, whereas worsening renal function during effective decongestion did not uniformly predict adverse renal or cardiovascular events. Studies evaluating venous excess ultrasound (VExUS)-guided and bioimpedance-guided strategies suggested that objective congestion assessment may improve decongestion phenotyping, although the available evidence remains limited. Overall, the findings support a renal-congestion framework in which kidney function is interpreted alongside congestion burden, diuretic response, perfusion status, and the trajectory of renal recovery. This approach may better distinguish high-risk persistent congestion from transient renal changes occurring during successful decongestion. Future prospective studies should determine whether combined renal-congestion phenotypes improve risk stratification beyond creatinine-based definitions of cardiorenal syndrome alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.